The revenue of Jinbo Bio-pharmaceutical for the first three quarters of 2023 reaching the highest value of the past five years

On Oct.26th,2023,ShanxiJinbo Bio-pharmaceutical Co.,Ltd (Stock Code: 832982,hereafter referred to as Jinbo Bio-pharmaceutical) released the financial report for the third quarter of 2023 at Beijing Stock Exchange.According to the financial report,the revenue of Jinbo Bio-pharmaceutical for the third quarter was 0.201 billion yuan,with a year-onyear increase of 106.43%;the net profit attributable to shareholders of listed companies was 82.8427 million yuan,with a year-onyear increase of 168.75%.The revenue of Jinbo Biopharmaceutical for the first three quarters of 2023 exceeded the annual revenue for 2022.In addition,since Jinbo Bio-pharmaceutical was listed in July 2023,bothits revenue and net profit attributable to parent company have increased,with a 3-digit growth rate.

Clariant purchasing IFF’s cosmetics material business

Clariant,a Swiss chemical company,announced to purchase Lucas Meyer Cosmetics,the material production department under the command of International Flavors &Fragrances (IFF) with a total cash of 0.81 billion U.S.dollars (approximately amount to RMB 5.92 billion yuan).The transaction is predicted to be completedin the first quarter of 2024.Founded in 1999,Lucas Meyer Cosmeticsis IFF’s department specially responsible for research,development and production ofinnovative materials and promotion of their application to cosmetics and personal care industries,whose products include active substance,emulsifiers,thickeners and other functional ingredients.Clariant claimed that it was the largest acquisition following its acquisition of the German company Südchemiein 2011.

Botanee making an overall arrangement in many areas

According to a message released by YOUMAGIC’s WeChat Official Account on Oct.26th,2023,YOUMAGIC’s R&D company Weimai Medical was financed by Botanee Group recently.The financing will consolidate technical barriers and improve the layout in the area of medical energy.YOUMAGIC’s R&D company Weimai Medical is an energy medicine research,development and conversion platform with the high-performance radio frequency energy system as a technical core.The investment from Botanee Group will further strengthen scientificity and professionalism,empowering the new future of skincare products with science and technology.It can be seen that Botaneeis going to make an overall arrangement in the area of cosmetic instruments.Viewed from the Double Eleven presale list for 2023 recently concluded,many brands of cosmetic instruments such as Amiro,Flossom and Ya-Man have showed a vigorous performance.At the same time,Botanee investedin areas such as makeup,skincare and medicine,and established foundations like Chonglou Capital to focus more on early investment.

Amore Pacific acquiring COSRX

On Oct.31st,2023,Amore Pacific announced to purchase the remaining 0.288 million shares held by the largest shareholder and special partyinterested of COSRX with 755.1 billion South-Korean Won (approximately amount to RMB 4.17 billion yuan).Itis known that Amore Pacific purchased COSRX’s 38.4% of equities in September 2021.After the acquisition,Amore Pacific will hold COSRX’s 93.2% of equities in total,and COSRX will become a subsidiary of Amore Pacific.According to public data,COSRX was founded in 2013,mainly engaging in sales of lowsensitivity skincare products.At present,it has established official stores at Tmall and Little Red Book,with product prices being 49～499 yuan.

Submission of compound materials for cosmetics restored

On Nov.1st,2023,the normal submission of compound materials,which had been blacklisted by the Material Safety Information Registration Platform,was restored quietly,causingindustry professionals to rush about telling the news.Before that,on Sep.4th,Chinese Academy of Inspection and Quarantine adopted three powerful measures.Then,the “Material Platform” and“Ordinary Cosmetics Registration Management System” were upgraded successively,no longer supporting the submission of compound materials.At the same time,the submission codes already obtained could not be used any more.As the industry held a waitand-see attitude,many industry professionals took an initiative to give feedback.Ten days later,a new turning point occurred.The“Ordinary Cosmetics Registration Management System” was again maintained and upgraded,and the function of export and filling of submission codes for compound materials was restored.However,the material platform was not renewed,only supporting the submission of single-component materials,yet new compound materials could still not be submitted.Now,this problem has finally resolved.

Cosmetics with “fake certificates” will soon perish

The Smart System for Reporting and Reviewing Cosmetics of National Medical Products Administration (NMPA)released the latest hint that NMPA will make public the label pictures of marketable products already uploaded by cosmetics registrantsin its website in accordance with relevant laws and regulations.According to the tips,when applying for registration of special cosmetics,an enterprise should note: The registrant should upload product label pictures;the registrant should be responsible for the authenticity and compliance of product label pictures;label pictures of special cosmetics will be made public.In fact,“making public label pictures of special cosmetics” was listedinto relevant regulations two years ago,but when to implement it had been a focal point cared by theindustry.At present,the policy has been fulfilled.Many industry professionals say that the mess of “fake certificates” lurking in the cosmetics industry will soon vanish.